Literature DB >> 22867942

Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption.

Li Sun1, Li Yang, Yan-Wei Xu, Hao Liang, Jing Han, Rui-Jie Zhao, Yan Cheng.   

Abstract

Hydroxysafflor yellow A (HSYA) is the main component of the safflower yellow pigments, the aqueous extract of safflower florets. We report here an experimental study for evaluating HSYA for their neuroprotective qualities on rats subjected to middle cerebral artery occlusion (60 min) and reperfusion (24h), an experimental model in which excessive production of reactive oxygen and nitrogen species has been found. In our data, biochemical analysis of tissue proteins showed that cerebral ischemia/reperfusion (I/R) injury resulted in significant elevation of carbonyl groups and nitrotyrosine in the brain of I/R in comparison to sham controls, indicating the occurrence of oxidative/nitrative modification to brain proteins. HSYA-treatment (1, 5 and 10mg/kg) inhibited I/R-induced protein oxidation and nitration. 12/15-Lipoxygenase (12/15-LOX), the enzyme implicated in oxidative stress of cerebral I/R, displayed overexpression in I/R rats. Elevated 12/15-LOX activity, estimated by the level of its metabolite 15-hydroxyeicosatetraenoic acid (15-HETE), was also induced by the challenge of cerebral I/R. Administration of HSYA 1, 5 and 10mg/kg reduced the upregulation of 12/15-LOX expression and activity in a dose-dependent manner. Moreover, the increase in blood-brain barrier (BBB) permeability evaluated by IgG leakage, Evans blue extravasation, and brain water content, respectively, was markedly alleviated by HSYA, indicating its protection against BBB disruption and brain edema following I/R insult. Taken together, these results demonstrate the neuroprotective properties of HSYA, which may be at least in part due to its potential to reduce protein oxidation and nitration, inhibit the upregulation of 12/15-LOX, and attenuate BBB breakdown.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867942     DOI: 10.1016/j.brainres.2012.07.047

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia.

Authors:  Robin L Haynes; Klaus van Leyen
Journal:  Dev Neurosci       Date:  2013-04-20       Impact factor: 2.984

2.  Hydroxysafflor Yellow A Improves Motor Dysfunction in the Rotenone-Induced Mice Model of Parkinson's Disease.

Authors:  Tian Wang; Lijie Wang; Cuiting Li; Bing Han; Zhenhua Wang; Ji Li; Yan Lv; Shuyun Wang; Fenghua Fu
Journal:  Neurochem Res       Date:  2017-01-17       Impact factor: 3.996

Review 3.  The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease.

Authors:  Yash B Joshi; Phillip F Giannopoulos; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2015-02-20       Impact factor: 14.819

4.  AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats.

Authors:  Zhifeng Qi; Feng Yan; Wenjuan Shi; Chencheng Zhang; Wen Dong; Yongmei Zhao; Jiangang Shen; Xunming Ji; Ke Jian Liu; Yumin Luo
Journal:  Transl Stroke Res       Date:  2014-05-09       Impact factor: 6.829

5.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

6.  The Value of Safflower Yellow Injection for the Treatment of Acute Cerebral Infarction: A Randomized Controlled Trial.

Authors:  Le-Jun Li; Yu-Mei Li; Ben-Yu Qiao; Shan Jiang; Xin Li; Hong-Ming Du; Peng-Cheng Han; Jiong Shi
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

7.  Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.

Authors:  Yang Wang; Chunhu Zhang; Weijun Peng; Zian Xia; Pingping Gan; Wei Huang; Yafei Shi; Rong Fan
Journal:  Mol Med Rep       Date:  2016-09-06       Impact factor: 2.952

8.  HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.

Authors:  Jun-Peng Pei; Li-Hong Fan; Kai Nan; Jia Li; Xiao-Qian Dang; Kun-Zheng Wang
Journal:  J Neuroinflammation       Date:  2017-05-03       Impact factor: 8.322

9.  Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2013-07-29

10.  Curcumin alleviates brain edema by lowering AQP4 expression levels in a rat model of hypoxia-hypercapnia-induced brain damage.

Authors:  Lin-Sheng Yu; Yan-Yan Fan; Guanghua Ye; Junli Li; Xiang-Ping Feng; Kezhi Lin; Miuwu Dong; Zhenyuan Wang
Journal:  Exp Ther Med       Date:  2016-01-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.